Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis (Q38187680)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 March 2014

Language	Label	Description	Also known as
English	Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis	scientific article published on 31 March 2014

Statements

scholarly article

1 reference

Europe PubMed Central

30 August 2017

0 references

Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis (English)

1 reference

Europe PubMed Central

30 August 2017

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Wen-Jian Liu

1

1 reference

Europe PubMed Central

30 August 2017

Xiao-Hong Tan

2

1 reference

Europe PubMed Central

30 August 2017

Xiu-Ping Luo

3

1 reference

Europe PubMed Central

30 August 2017

Bao-Ping Guo

4

1 reference

Europe PubMed Central

30 August 2017

Zhou-Ji Wei

5

1 reference

Europe PubMed Central

30 August 2017

Qing Ke

6

1 reference

Europe PubMed Central

30 August 2017

Sha He

7

1 reference

Europe PubMed Central

30 August 2017

Hong Cen

8

1 reference

Europe PubMed Central

30 August 2017

publication date

31 March 2014

1 reference

Europe PubMed Central

30 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

30 August 2017

55

1 reference

Europe PubMed Central

30 August 2017

12

1 reference

Europe PubMed Central

30 August 2017

2691-2698

1 reference

Europe PubMed Central

30 August 2017

Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

The role of mutations in epigenetic regulators in myeloid malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Acquired mutations in TET2 are common in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Mutation in TET2 in myeloid cancers

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

The JAK2 rs12343867 CC genotype frequently occurs in patients with splanchnic venous thrombosis without the JAK2V617F mutation: a retrospective study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Identifiers

10.3109/10428194.2014.893308

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38187680&oldid=1746238962"